Browsing: Nociscan

Aclarion, Inc. (ACON) shares jumped premarket after announcing a commercial partnership with Scripps Health to introduce its Nociscan diagnostic tool in Southern California.

Aclarion (Nasdaq: ACON) has announced its inaugural commercial agreement with Scripps Health in San Diego, California, which will extend access to its Nociscan technology and potentially benefit over 3.2 million people in the San Diego metropolitan area.